Michael German, MD
Otolaryngology · Salinas, CANPI 1336398627
Payments from drug & device makers
Across 105 payments — averaging $22.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$847
- GSK$524
- Smith+Nephew$137
- Optinose US, Inc.$134
- Kls-martin L.p.$129
- Stryker$110
- plus $452 from 15 others
What the payments were for
- Food & beverage$2,333100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 38 | $847 |
| GSK | 28 | $524 |
| Smith+Nephew | 4 | $137 |
| Optinose US, Inc. | 7 | $134 |
| Kls-martin L.p. | 6 | $129 |
| Stryker | 3 | $110 |
| Intersect ENT, Inc. | 2 | $103 |
| Amgen | 2 | $40 |
| Regeneron Healthcare Solutions, Inc. | 2 | $38 |
| Merck | 2 | $33 |
| Integra Lifesciences Corporation | 1 | $28 |
| Hospira, Inc. | 1 | $27 |
| Osteomed LLC | 1 | $25 |
| Sanofi-aventis U.S. LLC | 1 | $24 |
| Acclarent, Inc | 1 | $23 |
| KARL Storz Endoscopy-america | 1 | $23 |
| Lilly USA, LLC | 1 | $23 |
| Baxter Healthcare | 1 | $20 |
| Zyla Life Sciences, Inc. | 1 | $17 |
| Medtronic | 1 | $14 |
| Forte Bio-pharma LLC | 1 | $13 |
How this compares
$2,333 in reported general payments places this provider in the 65th percentile of 1,021 otolaryngology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ofloxacin | 49 | $4,246 |
| Ipratropium Bromide | 53 | $1,478 |
| Triamcinolone Acetonide | 45 | $601 |
| Omeprazole | 19 | $228 |
| Azelastine Hcl | 14 | $218 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 27 | $189 |
| Fluticasone Propionate | 12 | $81 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 11 | $71 |
| Methylprednisolone | 12 | $70 |
| Mupirocin | 13 | $60 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Salinas
- Randall OwRoseville$4.3M
- Amir MoradiVista$2.6M
- Brian WeeksSan Diego$1.6M
- Charles LimbSan Francisco$1.5M
- Andrew BerosSan Diego$688K
- Paul SchalchChula Vista$573K
- Steven DavisTorrance$544K
- Arnaud BewleySacramento$541K
- Keith BlackwellLos Angeles$349K
- Kalpna DurairajSun Valley$348K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.